Although the reported device expulsion (reported as "initial control of postpartum bleeding but expelled with pt.Vomiting."") is confounded by the patient's vomiting episode (as increase intra-abdominal pressure), based on the overall information currently provided in this report, there is a reasonable possibility that a potential malfunction (reported as ""initial control of postpartum bleeding but expelled with pt vomiting."") has occurred with the jada system whereby if the suspected malfunction were to recur at a time when the patient was not under close observation, this malfunction could possibly cause or contribute to a death or serious injury.Per the jada system ifu "note: confirm that the cervical seal is positioned at the external cervical os after the system is in place (cervical seal is filled and the vacuum is connected).Reposition jada if required to facilitate a seal." and "precaution: ensure jada is secured with tape to avoid unintentional dislodgement" out of an abundance of caution, the company will report this case as a malfunction mdr.
|
Alydia health received a jada experience survey (jes) on (b)(6) 2022, that had a handwritten statement in the area designated for 'what treatment(s) did you use to treat the abnormal postpartum uterine bleeding that was not controlled with the jada system?' that stated, "initial control of postpartum bleeding but expelled with pt vomiting." the patient in this case is described as multiparous and obese.She had an unassisted, induced vaginal delivery and her abnormal postpartum uterine bleeding or pph started within one hour after delivery.Prior to jada treatment she received unknown doses of cytotec, hemabate, and one gram of txa.The amount of blood loss prior to jada use was not reported.The cervical seal was filled with 120 cc of sterile fluid.The amount of blood evacuated with jada was reported as 75 ml.There is no other information for this case provided on this survey.There is limited information for this jes.A request was sent to the site on (b)(6) 2022, (b)(6) 2022, and (b)(6) 2022, to inquire if the lot number was available, if the device was retained, and questions regarding this case.This case will be amended if additional information is received.
|